Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
MGTA | Magenta Therapeutics, Inc. | Beetham Thomas W. | See Remarks | Nov 30, 2022 | Option Exercise | $0.94 | 3,000 | 2,820 | 19,897 | Dec 02, 2022, 04:26 PM | |
MGTA | Magenta Therapeutics, Inc. | Beetham Thomas W. | See Remarks | May 31, 2022 | Option Exercise | $0.99 | 3,000 | 2,970 | 16,897 | Jun 06, 2022, 04:05 PM | |
MGTA | Magenta Therapeutics, Inc. | Beetham Thomas W. | See Remarks | Sep 16, 2021 | Sale | $6.73 | 6,103 | 41,073 | 13,897 | Sep 20, 2021, 05:00 PM | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Beetham Thomas W. | EVP & Chief Legal Officer | Feb 03, 2021 | Sale | $22.09 | 2,477 | 54,717 | 297,523 | Feb 05, 2021, 06:55 PM | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Beetham Thomas W. | EVP & Chief Legal Officer | Jul 01, 2020 | Sale | $25.37 | 29,589 | 750,678 | 2,855 | Jul 02, 2020, 04:13 PM | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Beetham Thomas W. | EVP & Chief Legal Officer | Jun 10, 2020 | Sale | $13.33 | 27,504 | 366,628 | 43,341 | Jun 12, 2020, 05:50 PM | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Beetham Thomas W. | EVP & Chief Legal Officer | Apr 21, 2020 | Sale | $19.89 | 2,518 | 50,092 | 30,544 | Apr 22, 2020, 05:39 PM | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Beetham Thomas W. | EVP & Chief Legal Officer | Apr 20, 2020 | Sale | $19.06 | 47,423 | 903,882 | 32,107 | Apr 22, 2020, 05:39 PM | |
KNSA | Kiniksa Pharmaceuticals, Ltd. | Beetham Thomas W. | EVP & Chief Legal Officer | Feb 14, 2020 | Sale | $18.58 | 59 | 1,096 | 79,530 | Feb 19, 2020, 05:24 PM |